Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01018472 · ClinicalTrials.gov registry record · NA
Probiotics in Infants With Cyanotic Congenital Heart Disease
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01018472 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 12 participants.
The verdict
NCT01018472, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Infants with congenital heart disease have more frequent infections and exposures to antibiotics than healthy infants. It is unknown how congenital heart disease affects the development of bacterial colonization of the intestines. It is also unknown whether probiotics will change the bacteria in the intestine of infants with heart disease to become more like those of healthy infants without heart disease. This pilot trial is designed to address these two questions.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Bifidobacterium infantis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01018472
The ClinicalTrials.gov registry entry for NCT01018472 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01018472 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01018472 about?
NCT01018472 is a clinical study titled "Probiotics in Infants With Cyanotic Congenital Heart Disease". Infants with congenital heart disease have more frequent infections and exposures to antibiotics than healthy infants. It is unknown how congenital heart disease affects the development of bacterial colonization of the intestines. It is also unknown whether probiotics will change the bacteria in the...
What is the current status of trial NCT01018472?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2009-11. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01018472?
The interventions under investigation include: Placebo (OTHER), Bifidobacterium infantis (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01018472?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.